Skip to main content

Table 3 Postoperative outcomes and complications of patients

From: Perioperative chemotherapy versus adjuvant chemotherapy treatment for resectable locally advanced gastric cancer: a retrospective cohort study

Characteristics

NSA group

SA group

P-value

n = 218

n = 232

Postoperative hospital stay

  

0.158

 Mean (SD), d

11.9 (8.0)

10.6 (6.1)

 

Postoperative blood transfusion

27 (12.4)

33 (14.2)

0.566

Time to first flatus

  

0.208

 Mean (SD), d

3.73 (1.26)

3.46 (0.84)

 

Time to first liquid diet

  

0.368

 Mean (SD), d

4.24 (3.16)

4.16 (2.49)

 

Abdominal infection

5 (2.3)

4 (1.7)

0.745

Anastomotic stenosis

2 (0.9)

1 (0.4)

0.613

Anastomotic leakage

11 (5.0)

14 (6.0)

0.647

Dumping syndrome

3 (1.4)

7 (3.0)

0.341

Delayed gastric emptying

22 (10.1)

18 (7.8)

0.385

Wound problem

8 (3.7)

6 (2.6)

0.508

Gastrointestinal bleeding

2 (0.9)

3 (1.3)

1.000

Pleural effusion

4 (1.8)

4 (1.7)

1.000

Pneumonia

6 (2.8)

9 (3.9)

0.506

Overall

54 (24.8)

46 (19.8)

0.207

  1. Values are presented as number (%) unless otherwise indicated. NSA: neoadjuvant chemotherapy plus surgery plus adjuvant chemotherapy; SA: surgery plus adjuvant chemotherapy; SD: standard deviation